Article de revue

An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine

New vaccine technologies may improve the acceptability, delivery (potentially enabling self-administration), and product efficacy of influenza vaccines. One such technology is the microneedle patch (MNP), a skin delivery technology currently in development. Although MNPs hold promise in preclinical studies, their potential economic and epidemiologic impacts have not yet been evaluated.

Was this useful?
Log in to vote

Ajouté par: Marilyn Kelly

Ajouté le: 2017-02-23 10:31:11

Consultations: 3845

Liens